ERBB2 and breast cancer: It may be speculated that tumor dependency on HER2 signaling is determined by total HER2 in a larger extent than p95HER2 in this cohort of HER2-positive breast cancer and the tumor dependency on HER2 signaling in turn would determine the treatment result.